LCM Biosensor Technologies is a deep -tech life -sciences NY based company that is transforming the way people monitor their health using a sensor-based wearable technology that detects the earliest stages of diabetes and other life-threatening conditions.
LCM has discovered an innovative needle -free biomarkers monitoring platform using an optical-osmotic transducer that reads blood sugar levels continuously through the skin matching the accuracy of an FDA approved finger-prick glucose meters and provides real-time tracking of various health biomarkers at the tissue, cellular, and molecular levels.
The primary focus is on continuous glucose monitoring. The goal is to move from a hardware – centric wearable to a service - centric “Healthspan Compass” that empowers users – particularly those without confirmed diabetic issues - to detect early warning signs and optimize their health through data-driven lifestyle corrections.
Our Global Mission is to help people to predict early and prevent Diabetes and other chronic conditions to extend the healthspan - the duration of life free from chronic diseases - using LCM Biosensor technologies.
Diabetes affects around 600 million people across the globe including 38 million in the USA. Type 2 Diabetes is a major risk factor for the whole host of lethal diseases (cardiovascular, renal, metabolic) which collectively are the leading cause of deaths across the globe, killing 20 M people each year.
Diabetes places significant pressure on healthcare costs. The total annual cost of diabetes in the U.S. in 2022 was $413 billion. People with diagnosed diabetes now account for one of every four healthcare dollars spent in the U.S.
NEEDLE – FREE BIOMARKERS MONITORING PLATFORM
The solution to this one of most dangerous life-threatening conditions is a service-centric ecosystem that helps users to detects the earliest stages of diabetes using a portable needle –free glucose monitoring device which has been on of the biggest ambitions in wearables for decades.
We have developed a different approach. Through re-examining the basic physics of glucose interaction with the living tissue, we first built a scientific groundwork of Skin Biophysics, or the Physics of Intercellular Substance – Living Condensed Matter (LCM) Physics.
We discovered that glucose interactionswith the hyaluronic acid under physiological conditions leads to the formation of a living condensed matter that acts as a natural biosensor with the selectivity to glucose molecules and sensitivity to heat energy and functions as a glucose sensing calorimeter that converts glucose concentration change into osmotic pressure change.
The ecosystem of Preventative Healthcare and Wellness:
A service – centric LCM Healthspan Compassis a Real Time Laboratory on the wrist for needle-free tracking health biomarkers that empowers users to detect early stages of chronic diseases and optimize their health through data-driven lifestyle corrections.
- Early Prediction and Prevention Diabetes and related conditions;
- Obesity-related diseases prediction & prevention;
- Nutrition as a Prevention;
- Breast Cancer early detection.
Address: USA 20 Maple Avenue, East Setauket, NY 11733
